These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 7121128)

  • 1. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitivity of anaerobes to 8 antibiotics].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):645-7. PubMed ID: 3534760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of antimicrobial resistance and resistance transfer in anaerobic bacteria.
    Tally FP; Malamy MH
    Scand J Infect Dis Suppl; 1982; 35():37-44. PubMed ID: 6300995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of antibiotic resistant strains of Bacteroides fragilis.
    Scher KS
    Surg Gynecol Obstet; 1988 Sep; 167(3):175-9. PubMed ID: 3413646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R; Petzold S; Fille M; Rodloff AC
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
    Dubreuil L; Derriennic M; Reynaud A; Devos J; Romond C; Courtieu A
    Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
    Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
    Dornbusch K; Nord CE; Olsson-Liljeqvist B
    Scand J Infect Dis Suppl; 1979; (19):17-25. PubMed ID: 37593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance and resistance transfer in anaerobic. A review.
    Tally FP; Malamy MH
    Scand J Gastroenterol Suppl; 1984; 91():21-30. PubMed ID: 6377471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group.
    Snydman DR; Jacobus NV; McDermott LA
    J Antimicrob Chemother; 2005 Jun; 55(6):1024-8. PubMed ID: 15824092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility to antimicrobial drugs of enterotoxin producing strains of Bacteroides fragilis isolated from different countries].
    Obuch-Woszczatyński P; Rokosz A; Sawicka-Grzelak A; Pituch H; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2002; 54(3):253-8. PubMed ID: 12632660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
    Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
    Cáceres M; Carera E; Palmgren AC; Nord CE
    Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
    Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
    Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.